Zevra Therapeutics, Inc. (ZVRA)
NASDAQ·Healthcare·Biotechnology
$9.95
+1.43%
Mkt Cap $595.88M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (12 analysts)
$24.25
Range $23.00 – $26.00
Implied Upside
+143.7%
Consensus $24.25 vs current $9.95
NASDAQ·Healthcare·Biotechnology
$9.95
+1.43%
Mkt Cap $595.88M
Buy
2
Hold
0
Sell
0
Price Target (12 analysts)
$24.25
Range $23.00 – $26.00
+143.7%
Consensus $24.25 vs current $9.95